Tumor heterogeneity and the dilemma of antioxidant therapies in cancer

Ann Transl Med. 2022 Oct;10(19):1074. doi: 10.21037/atm-22-4219.

Authors

Heloisa Sobreiro Selistre-de-Araujo¹, Bianca Cruz Pachane¹, Wanessa Fernanda Altei^{2

3}

Affiliations

¹ Biochemistry and Molecular Biology Laboratory, Department of Physiological Sciences, Universidade Federal de São Carlos (UFSCar), São Carlos, Brazil.
² Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.
³ Radiation Oncology Department, Barretos Cancer Hospital, Barretos, Brazil.

No abstract available

Publication types

Editorial
Comment